Results 231 to 240 of about 61,734 (360)

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy [PDF]

open access: bronze, 2006
Perry Elliott   +7 more
openalex   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk   +12 more
wiley   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li   +12 more
wiley   +1 more source

Septal Bipolar Ablation to Prevent Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Implantation. [PDF]

open access: yesCirc Cardiovasc Interv, 2023
Hoskins MH   +12 more
europepmc   +1 more source

1038 Increased prevalence of aortic valve calcification and stenosis in patients with left ventricular hypertrophy and dynamic outflow tract obstruction [PDF]

open access: bronze, 2006
Daniel Monakier   +7 more
openalex   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy [PDF]

open access: bronze, 2007
J. S. Shah   +14 more
openalex   +1 more source

A Novel De Novo Splice Acceptor Variant in BICD2 Is Associated With Spinal Muscular Atrophy

open access: yes
American Journal of Medical Genetics Part A, Volume 197, Issue 4, April 2025.
Giulia F. Del Gobbo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy